TargetingOne received EU CE market approval for the whole chain of nucleic acid testing products for the novel coronavirus

release date：2021-08-11

Recently, the whole chain of novel coronavirus nucleic acid detection products developed by TargetingOne has been granted CE market access in the European Union, providing two technical solutions for global anti-epidemic with excellent fluorescent quantitative PCR (qPCR) and digital PCR, which have outstanding advantages such as high sensitivity, accurate results and easy operation.

Novel Coronavirus(2019-nCov) detection products received the EU CE market access qualification

The whole chain of nucleic acid testing products approved by TargetingOne include disposable sampler (swab sample), disposable sampler (saliva sample), fully automated nucleic acid extractor, nucleic acid extraction reagent, novel coronavirus (SARS-CoV-2) nucleic acid detection kit (fluorescent PCR method), novel coronavirus (SARS-CoV-2)/influenza A/ B virus Nucleic acid detection kits (fluorescent PCR method), we providing excellent solutions for the whole process of nucleic acid detection of novel coronaviruses.

微信图片_20210811151834.jpg

Full Chain Solution for Novel Coronavirus Testing

Disposable sampler (swab sample, saliva sample)

Home test, easy to use
Higher biosafety, sampling and virus inactivation synchronization
Wide range of specifications and scenes to meet different sampling needs of customers
Effectively maintain virus activity, facilitate downstream immunization research
Effectively improve the detection rate of positive viruses and avoid false negatives